The Iraqi Pharmaceutical Industry: Strengths, Weaknesses, Opportunities and Threats

Executive Summary
The pharmaceutical industry in Iraq has historically faced structural and regulatory challenges; however, recent reforms and emerging opportunities have created a more favorable environment for growth. This report analyzes the pharmaceutical manufacturing sector in Iraq, examining its current state, key constraints, and future potential, with a particular focus on industrial capacity, regulation, and investment readiness

This report draws upon a range of sources, including government data, industry reports, and expert analysis, to provide valuable insights into the Iraqi pharmaceutical market. The highlights are as follows:

This report shines a bright light on many aspects of the pharmaceutical sector, mainly the industrial part of the pharmaceutical industry. Iraqi manufacturers have been resilient through years of international sanctions, security struggles, shortage of expertise, and lack of governmental support, but many are still supplying the Iraqi market with excellent quality medicine. The conducted strengths, weaknesses, opportunities, and threats (SWOT) analysis provides insight into this vital niche of manufacturing, which is of significant importance to the well-being of Iraq as an economy.

It is our hope that this report, with the proper strategies and investments, may be used as a resource by local and international pharmaceutical companies to contribute to the improvement of the healthcare system in the country.